Saidat Fehintola Olaniran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saidat Fehintola Olaniran has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abdulmajeed Atiah Alharbi
Department of Mathematics, Taibah University, Faculty of Science, Al-Munawara, Saudi Arabia
1 shared publicationDaniel Stahl
Department of Biostatistics & Health Informatics, King’s College London, London, UK
1 shared publicationDiana Shamsutdinova
Department of Biostatistics & Health Informatics, King’s College London, London, UK
1 shared publicationEwan Carr
Department of Biostatistics & Health Informatics, King’s College London, London, UK
1 shared publicationFelix Zimmer
Independent researcher, Leipzig, Germany
1 shared publicationGordon Forbes
Department of Biostatistics & Health Informatics, King’s College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 13 July 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Adaptive Gaussian process search for simulation-based sample size estimation in clinical prediction models: validation of the pmsims R package
Determining an adequate sample size is essential for developing reliable and generalisable clinical prediction models, yet practical guidance on selecting
- 13 July 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Open AccessAdaptive Gaussian process search for simulation-based sample size estimation in clinical prediction models: validation of the pmsims R package
Determining an adequate sample size is essential for developing reliable and generalisable clinical prediction models, yet practical guidance on selecting
- Open Access
- 22 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-24
Mixed effect gradient boosting for high-dimensional longitudinal data
High-dimensional longitudinal data present significant analytical challenges due to intricate within-subject correlations and an overwhelming ratio of predictors to observations. To address these challenges, we introduce Mixed-Effect Gradient Boosting (MEGB), a novel R package that synergises gradient boosting with mixed-effects modelling to simultaneously account for population-level fixed effects and subject-specific random variability. MEGB provides a unified framework for analysing repeated measures data that accommodates complex covariance structures while harnessing gradient boosting’s inherent regularisation for robust feature selection and prediction. In comprehensive simulations spanning linear and nonlinear data-generating processes, MEGB achieved 35-76% lower mean squared error (MSE) compared to state-of-the-art alternatives like Mixed-Effect Random Forests (MERF) and REEMForest, while maintaining 55-70% true positive rates for variable selection in ultra-high-dimensional regimes \((p=2000)\). Demonstrating practical utility, we applied MEGB to maternal cell-free plasma RNA data \((n=12\) subjects, \(p=33,297\) transcripts), where it identified 9 key placental transcripts driving fetal RNA dynamics across pregnancy trimesters.- 22 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-24
Open AccessMixed effect gradient boosting for high-dimensional longitudinal data
High-dimensional longitudinal data present significant analytical challenges due to intricate within-subject correlations and an overwhelming ratio of predictors to observations. To address these challenges, we introduce Mixed-Effect Gradient Boosting (MEGB), a novel R package that synergises gradient boosting with mixed-effects modelling to simultaneously account for population-level fixed effects and subject-specific random variability. MEGB provides a unified framework for analysing repeated measures data that accommodates complex covariance structures while harnessing gradient boosting’s inherent regularisation for robust feature selection and prediction. In comprehensive simulations spanning linear and nonlinear data-generating processes, MEGB achieved 35-76% lower mean squared error (MSE) compared to state-of-the-art alternatives like Mixed-Effect Random Forests (MERF) and REEMForest, while maintaining 55-70% true positive rates for variable selection in ultra-high-dimensional regimes \((p=2000)\). Demonstrating practical utility, we applied MEGB to maternal cell-free plasma RNA data \((n=12\) subjects, \(p=33,297\) transcripts), where it identified 9 key placental transcripts driving fetal RNA dynamics across pregnancy trimesters.